je.st
news
FDA OKs Merck hepatitis C drug, adding to patient choices
2016-01-29 02:48:54| Biotech - Topix.net
Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. The combination pill includes the medications elbasvir and grazoprevir, which attack the virus in two different ways.
Tags: drug
adding
patient
choices
Category:Biotechnology and Pharmaceuticals